BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Total Liabilities

Latest total liabilities for GRNAW: $92M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$91.75M
↑ 56.56% YoYΔ $33.15M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Total Liabilities History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Total Liabilities Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a total liabilities of $92M. That compares with $59M in the prior-year period — up 56.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's total liabilities is now $92M (was $59M) — a 56.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's total liabilities over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $92M That compares with $59M in the prior-year period — up 56.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $92M) with ownership activity and broader fundamentals.